Yumanity Therapeutics Inc (YMTX) Stock
YMTX is no longer traded. Yumanity Therapeutics was delisted from the Nasdaq in December 2022.
Prices on this page are historical; the last trade was December 16, 2022 at $1.89.
Yumanity Therapeutics stock price history
YMTX final trading statistics
- Final close
- $1.89
- Final trading day
- Dec 16, 2022
- Market cap at delisting
- $20.52M
- Shares outstanding
- 10.86M
- Final 52-week range
- $0.95 – $3.78
- Avg. volume (final 3 mo.)
- 121,948
- All-time high (split-adj.)
- $140.60 · Jan 2021
- All-time low (split-adj.)
- $0.56 · Aug 2019
- Return since IPO
- +99.4%
- Beta
- —
- Book value / share
- $0.50
- Price / book
- 3.75
Yumanity Therapeutics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $8.04M | -$39.5M | -$26.95 |
| FY2020 | $6.90M | -$57.5M | $18.32 |
| FY2019 | $0.00 | -$31.2M | -$23.00 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Yumanity Therapeutics Inc
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration. Its lead program is YTX-7739, a novel small molecule that is in Phase I clinical trial for the treatment of Parkinson's disease and related disorders of a-synuclein. The company is also developing YTX-9184, which is in preclinical studies to treat neurological disorders. Yumanity Therapeutics Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
Yumanity Therapeutics stock FAQ
What happened to Yumanity Therapeutics stock?
Yumanity Therapeutics stock was delisted from the Nasdaq. Its final close was $1.89 on December 16, 2022.
Is YMTX stock still trading?
No. YMTX was delisted from the Nasdaq in December 2022 and no longer trades on a U.S. exchange.
What was the last price of YMTX stock?
YMTX closed at $1.89 on its final trading day, December 16, 2022, for a market value of about $20.52M.
What were Yumanity Therapeutics's revenue and earnings in its last full fiscal year?
Yumanity Therapeutics reported revenue of $8.04M and net income of -$39.5M in fiscal 2021, its last full year as a public company.
When did Yumanity Therapeutics go public?
Yumanity Therapeutics Inc stock began trading on February 11, 2016.